Table 3.
Unadjusted and adjusted odds ratio for 28-day mortality in cancer patients who were intubated in the emergency department, stratified by the presence of lung cancer and metastasis.
| Non-lung cancer patients | Lung cancer patients | ||||
|---|---|---|---|---|---|
| Without metastasis (n = 43) | With metastasis (n = 68) | Without metastasis (n = 21) | With metastasis (n = 80) | p-value | |
| No. of dead patients | 19 (44.2) | 43 (63.2) | 11 (52.4) | 53 (66.2) | 0.012 |
| Unadjusted OR (95% CI) | Reference | 2.90 (1.32–6.40) | 1.86 (0.65–5.34) | 3.31 (1.53–7.17) | — |
| Adjusted OR* (95% CI) | Reference | 4.24 (1.32–13.65) | 5.89 (1.48–23.36) | 7.17 (2.14–24.01) | — |
OR, odds ratio; CI, confidence interval; BMI, body mass index; CPR, cardiopulmonary resuscitation; SOFA, sequential organ failure assessment.
*The clinical variables entered into the model included age, sex, BMI, chronic liver disease, chronic pulmonary disease, disease status, indication of intubation (respiratory failure without sepsis [reference] vs. sepsis-related respiratory failure or CPR), performance status, SOFA score, ongoing treatment plan, multiple metastases (defined as two or more metastatic lesions), and groups stratified by cancer type and the presence of metastasis (non-lung cancer without metastasis [reference] vs. non-lung cancer with metastasis, lung cancer without metastasis, or lung cancer with metastasis.